In Silico Clinical Trials for Cardiovascular Disease

DOI :

10.3791/63573-v

•

May 27th, 2022

•

1,284 Views

Nenad Filipovic^1,2, Igor Saveljic^2,3, Tijana Sustersic^1,2, Miljan Milosevic^2,3, Bogdan Milicevic^1,2, Vladimir Simic^2,3, Milos Ivanovic^1,4, Milos Kojic^1,5

¹Bioengineering Research and Development Center BioIRC, ²Faculty of Engineering, University of Kragujevac, ³Institute for Information Technology, University of Kragujevac, ⁴Faculty of Science, University of Kragujevac, ⁵Serbian Academy of Science and Arts

Chapters

This protocol demonstrates the workflow of the SILICOFCM platform for automatically generating a parametric model of the left ventricle from patient-specific ultrasound images by applying a multi-scale electromechanical model of the heart. This platform enables in silico clinical trials intended to reduce real clinical trials and maximize positive therapeutic outcomes.

-- Vistas

Videos relacionados

Autologous Endothelial Progenitor Cell-Seeding Technology and Biocompatibility Testing For Cardiovascular Devices in Large Animal Model

Quantification of Global Diastolic Function by Kinematic Modeling-based Analysis of Transmitral Flow via the Parametrized Diastolic Filling Formalism

Generation of a Three-dimensional Full Thickness Skin Equivalent and Automated Wounding

Production, Characterization and Potential Uses of a 3D Tissue-engineered Human Esophageal Mucosal Model

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Fabrication of Custom Agarose Wells for Cell Seeding and Tissue Ring Self-assembly Using 3D-Printed Molds

Comparable Decellularization of Fetal and Adult Cardiac Tissue Explants as 3D-like Platforms for In Vitro Studies

Generation of Cationic Nanoliposomes for the Efficient Delivery of In Vitro Transcribed Messenger RNA

In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox

Preparation of Mesh-Shaped Engineered Cardiac Tissues Derived from Human iPS Cells for In Vivo Myocardial Repair